A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14)

Acta Haematologica

Volumn 101, Issue 4, 1999, Pages 197-201

  Sonoki, Takashi ^a   Matsuzaki, H ^a   Satterwhite, E ^b   Nakazawa, N ^c   Hata, H ^a   Tucker, P W ^b   Taniwaki, M ^c   Kuribayashi, N ^a   Harada, N ^a   Matsuno, F ^a   Mitsuya, H ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

14q32 translocation; Plasma cell leukemia; PRAD1 Cyclin D1; t(11; 14); t(2; 14)

Indexed keywords

CYCLIN D1; DNA FRAGMENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 14Q; CHROMOSOME 2Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 2; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE REARRANGEMENT; GENETIC LINKAGE; HUMAN; HUMAN CELL; IMMUNOELECTROPHORESIS; IMMUNOGLOBULIN GENE; KARYOTYPE; MALE; MONONUCLEAR CELL; NORTHERN BLOTTING; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ALLELES; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 2; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LAMBDA-CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, PLASMACYTIC; MALE; MIDDLE AGED; NUCLEOTIDE MAPPING; TRANSLOCATION, GENETIC;

EID: 0032784087     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040953     Document Type: Article

References (30)

1. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM: Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 1996;93:13931-13936.
2. Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M: The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 1997;90:526-534.
3. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL: Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma: Association with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 1997;16: 260-264.
4. Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, Marzella R, Rocchi M, Otsuki T, Lombardi L, Maiolo AT, Neri A: A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood 1997;90: 4062-4070.
5. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RSK, Dalla-Favera R: Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 1997;17:226.
6. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994;84: 1361-1392.
7. Sawyer JR, Waldron JA, Jagannath S, Barlogie B: Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 1995;82:41-49.
8. Lai JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T: Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 1995;85: 2490-2497.
9. Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH, Naucke S, Sawyer JR: Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 1995;86:4250-4256.
10. Weh HJ, Bartl R, Seeger D, Selbach J, Kuse R, Hossfeld DK: Correlations between karyotype and cytologic findings in multiple myeloma. Leukemia 1995;9:2119-2122.
11. Kobayashi H, Saito H, Kitano K, Kiyosawa K, Gaun S, Aoki K, Narita A, Watanabe M, Uchimaru K, Motokura T: Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32). Acta Haematol 1995;94:199-203.
12. Meeus P, Stul MS, Mecucci C, Cassiman JJ, Van den Berghe H: Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma. Cancer Genet Cytogenet 1995;83:25-27.
13. Shimazaki C, Goto H, Araki S, Tatsumi T, Takahashi R, Hirai H, Kikuta T, Yamagata N, Ashihara E, Inaba T, Fujita N, Suzuki R, Nakagawa M: Overexpression of PRAD1/cyclin D1 in plasma cell leukemia with t(11;14)(q13;q32). Int J Hematol 1997;66:111-115.
14. Chesi M, Bergsagel PL, Brents LA, Smith CA, Gerhard DS, Kuehl WM: Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 1996;88:674-681.
15. Heim S, Miteleman F: Multiple myeloma and plasma cell leukemia in chronic lymphoproliferative disorders; in Heim S, Miteleman F (eds): Cancer Cytogenetics, ed 2. New York, Wiley-Liss, 1995, pp 237-265.
16. Vaandrager JW, Kluin P, Schuuring E: The (t(11;14)(q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centrometric from the cyclin D1 gene. Blood 1997;89:349-350.
17. Yoffe G, Howard-Peebles PN, Smith RG, Tucker PW, Buchanan GR: Childhood chronic lymphocytic leukemia with (2;14) translocation. J Pediatr 1990;116:114-117.
18. Sonnier JA, Buchanan GR, Howard-Peebles PN, Rutledge J, Smith RG: Chromosomal translocation involving the immunoglobulin kappa-chain and heavy-chain loci in a child with chronic lymphocytic leukemia. N Engl J Med 1983;309:590-594.
19. Richardson AL, Humphries CG, Tucker PW: Molecular cloning and characterization of the t(2;14) translocation associated with childhood chronic lymphocytic leukemia. Oncogene 1992;7:961-970.
20. Nishida K, Taniwaki M, Misawa S, Abe T: Nonrandom rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell phenotype. Cancer Res 1989;49:1275-1281.
21. Lautner-Rieske A, Hameister H, Barbi G, Zachau HG: Mapping immunoglobulin gene-related DNA probes to the central region of normal and pericentrically inverted human chromosome 2. Genomics 1993;16:497-502.
22. An International System for Human Cytogenetic Nomenclature (ISCN 1995): Report of the standing committee on human cytogenetic nomenclature. Cytogenet Cell Genet 1995;31: 1.
23. Takashima T, Itoh M, Ueda Y, Nishida K, Tamaki T, Misawa S, Abe T, Seto M, Machii T, Taniwaki M: Detection of 14q32.33 translocation and t(11:14) in interphase nuclei of chronic B-cell leukemia/lymphomas by in situ hybridization. Int J Cancer 1997;72:31-38.
24. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Novell PC, Croce CM: Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984;224: 1403-1406.
25. Sonoki T, Hata H, Kuribayashi N, Yoshida M, Harada N, Nagasaki A, Kimura T, Matsuno F, Mitsuya H, Matsuzaki H: Expression of PRAD1/Cyclin D1 in plasma cell malignancy: Incidence and prognostic aspects. Br J Haematol 1999;104:614-617.
26. Ohtsuki T, Yawata Y, Wada H, Sugihara T, Mori M, Namba M: Two human myeloma cell lines, amylase-producing KMS-12PE and amylase-non-producing KMS-12BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32). Br J Haematol 1989;73:199-204.
27. Matsuzaki H, Hata H, Asou N, Suzushima H, Akahoshi Y, Yoshida M, Nagakura S, Ishii T, Sanada I, Takatsuki K: Establishment and characterization of acute B-cell lymphocytic leukemia cell line showing (8;14) and (14;18) chromosome translocation. Acta Haematol 1990;84:156-161.
28. Hallek M, Bergsagel PL, Anderson KC: Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 1998;91:3-21.
29. Kawano MM, Mahmoud MS, Ishikawa H: Cyclin D1 and p16INK4A are preferentially expressed in immature and mature myeloma cells, respectively. Br J Haematol 1997;99: 131-138.
30. Zhang J, Alt FW, Honjo T: Regulation of class switch recombination of the immunoglobulin heavy chain genes; in Honjo T, Alt FW (eds): Immunoglobulin genes, ed 2. London, Academic Press, 1995, pp 235-265.